Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CGON
LGND
Add up to 3 more stocks
CGON
CG Oncology Inc.
-7.34%
$63.66-5.04Delayed quote: Oct 6, 2026, 1:20 PM EDT
Market Cap
$5.62B
52W Range
$35.80 - $80.97
LGND
Ligand Pharmaceuticals Incorporated
-3.54%
$295.91-10.86Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$5.93B
52W Range
$175.89 - $326.63
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 31.65 |
| Forward P/E | N/A | 31.80 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.46 | 6.13 |
| P/S Ratio | 901.64 | 20.41 |
| P/FCF Ratio | N/A | 45.14 |
| EV/EBITDA | N/A | 44.87 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -15.0% | 98.6% |
| Operating Margin | -4722.1% | 17.6% |
| Net Margin | -3602.7% | 67.9% |
| ROE | -21.8% | 20.4% |
| ROA | -20.7% | 9.0% |
| ROIC | -24.3% | 3.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 22.22 | 31.18 |
| Quick Ratio | 22.20 | 30.96 |
| Debt/Equity | 0.01 | 1.17 |
| Interest Coverage | N/A | 10.01 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.